论文部分内容阅读
目的探讨中药复肝灵治疗肝脏疾病的临床疗效。方法选取2012年1月—2015年1月赣州市皮肤病医院收治的肝脏疾病患者92例,按随机数字表法分为试验组与对照组,各46例。对照组患者予以传统治疗,试验组在对照组基础上予以中药复肝灵治疗。观察两组患者治疗前后丙氨酸氨基转移酶(ALT)、总胆红素(TBi L)水平及不良反应发生情况。结果治疗前两组患者ALT、TBi L水平比较,差异无统计学意义(P>0.05);治疗后试验组患者ALT、TBi L水平低于对照组,差异有统计学意义(P<0.05);两组患者均未发生严重不良反应。结论中药复肝灵治疗肝脏疾病的临床疗效显著,可改善患者肝功能,且不良反应少。
Objective To investigate the clinical efficacy of Fugangan for the treatment of liver diseases. Methods From January 2012 to January 2015, 92 patients with liver diseases admitted to Ganzhou Dermatology Hospital were divided into experimental group and control group according to the random number table method, with 46 cases in each group. Patients in the control group were treated with traditional Chinese medicine. The experimental group was treated with traditional Chinese medicine Fugangan Ling on the basis of the control group. The levels of alanine aminotransferase (ALT), total bilirubin (TBi L) and the incidence of adverse reactions in both groups before and after treatment were observed. Results There was no significant difference in the levels of ALT and TBi L between the two groups before treatment (P> 0.05). After treatment, the levels of ALT and TBi L in the experimental group were lower than those in the control group (P <0.05). No serious adverse reactions occurred in both groups. Conclusion The clinical efficacy of traditional Chinese medicine Fuganling in treating liver diseases is significant, which can improve the liver function of patients with less adverse reactions.